LI
KYNB

LMCG Investments’s Kyntra Bio KYNB Stock Holding History

LMCG Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3.97M Buy
7,248
+3,413
+89% +$2.07M 0.09% 318
2015
Q2 		$2.25M Buy
+3,835
New +$2.23M 0.05% 349

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LMCG Investments's KYNB Position: Q3 2015 in Review

LMCG Investments increased its Kyntra Bio (KYNB) stake by 89% in Q3 2015, buying an estimated $2.07M and bringing the position to 7,248 shares worth $3.97M. The position accounts for 0.09% of the portfolio, ranked #318.

LMCG Investments first reported a position in KYNB in Q2 2015 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold KYNB as of Q3 2015.

  • LMCG Investments held 7,248 shares of Kyntra Bio worth $3.97M as of Q3 2015.
  • LMCG Investments bought 3,413 Kyntra Bio shares in Q3 2015, an estimated $2.07M.
  • Kyntra Bio made up 0.09% of LMCG Investments's portfolio in Q3 2015, its #318 holding.
  • LMCG Investments first reported a position in Kyntra Bio in Q2 2015 and has held it in 2 quarters since.
  • 118 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.